Portal Innovations Expands Life Sciences Incubator Network
PROVIDENCE, R.I., Feb. 11, 2026 — Portal Innovations announced the expansion of its Powered by Portal venture development platform...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
PROVIDENCE, R.I., Feb. 11, 2026 — Portal Innovations announced the expansion of its Powered by Portal venture development platform...
Houston, Texas — February 10, 2026: FibroBiologics, Inc., a clinical-stage biotechnology company advancing fibroblast-based therapeutics, announced that its Chairman...
London, United Kingdom | January 29, 2026 — LifeArc Ventures, the venture capital arm of medical research organization LifeArc,...
Basel, Switzerland – October 23, 2025: Swiss Rockets AG has announced a strategic partnership with Squirro AG aimed at...
FREMONT, Calif., Oct. 10, 2025 /PRNewswire/ — Alamar Biosciences, a leader in precision proteomics, today announced the launch of...
